NCT07561476

Brief Summary

The goal of this clinical trial is to evaluate whether Matrix Rhythm Therapy (MRT), when added to a home exercise program, is effective in reducing symptoms of Restless Legs Syndrome (RLS) in adult women. It will also examine the effects of treatment on sleep quality, daytime sleepiness, depressive symptoms, and quality of life. The main questions it aims to answer are: Does Matrix Rhythm Therapy reduce the severity of Restless Legs Syndrome symptoms? Does Matrix Rhythm Therapy improve sleep quality and insomnia symptoms? Does Matrix Rhythm Therapy improve quality of life and emotional well-being? Researchers compared participants receiving Matrix Rhythm Therapy plus home exercise with participants receiving home exercise alone. Participants will: Be randomly assigned to one of two study groups Receive a home exercise program for 5 weeks Receive Matrix Rhythm Therapy sessions twice weekly for 5 weeks if assigned to the intervention group Complete questionnaires and clinical assessments before and after treatment

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 4, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 23, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 21, 2022

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

April 24, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 1, 2026

Completed
Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

1.1 years

First QC Date

April 24, 2026

Last Update Submit

April 24, 2026

Conditions

Keywords

Restless Legs Syndrome, Matrix Rhythm Therapy ,Exercise Therapy ,Sleep Quality,Physical Therapy ,Quality of Life

Outcome Measures

Primary Outcomes (1)

  • International Restless Legs Syndrome Rating Scale

    Change in Restless Legs Syndrome severity assessed using the International Restless Legs Syndrome Rating Scale

    Baseline and 6 weeks

Study Arms (2)

Matrix Rhythm Therapy + Home Exercise

EXPERIMENTAL

Participants received Matrix Rhythm Therapy in addition to a structured home exercise program. Matrix Rhythm Therapy was applied twice weekly for 5 weeks (10 sessions total, 60 minutes each session).

Device: MATRİX RHYTHM THERAPYBehavioral: HOME EXERCISE PROGRAM

Home Exercise Alone

ACTIVE COMPARATOR

Participants received a structured home exercise program for 5 weeks.

Behavioral: HOME EXERCISE PROGRAM

Interventions

Matrix Rhythm Therapy was applied using a certified vibration device delivering rhythmic mechanical oscillations to the lower extremity muscles. Treatment sessions were administered according to the study protocol for participants with Restless Legs Syndrome.

Matrix Rhythm Therapy + Home Exercise

Participants in the control group received a home exercise program consisting of stretching and therapeutic exercises for the lower extremities, performed according to the study protocol.

Home Exercise AloneMatrix Rhythm Therapy + Home Exercise

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly individuals who self-identified as women were eligible to participate.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female participants aged 18 to 65 years Diagnosis of Restless Legs Syndrome Willingness to participate and provide informed consent Ability to comply with treatment sessions and assessments -

You may not qualify if:

  • Pregnancy Neurological or musculoskeletal disorders affecting lower extremities Severe systemic disease Current participation in another clinical study Inability to complete treatment sessions or assessments Use of medications that could significantly affect Restless Legs Syndrome symptoms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pamukkale University Faculty of Physical Therapy and Rehabilitation

Denizli, Denizli, 20070, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Restless Legs Syndrome

Condition Hierarchy (Ancestors)

Nervous System DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersParasomniasMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The assessor who performed baseline and post-treatment outcome evaluations was blinded to group assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned in parallel to one of two groups: Matrix Rhythm Therapy plus home exercise program, or home exercise program alone.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

April 24, 2026

First Posted

May 1, 2026

Study Start

May 4, 2021

Primary Completion

June 23, 2022

Study Completion

September 21, 2022

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to participant confidentiality and institutional data protection policies.

Locations